Literature DB >> 29086074

A primary extradural malignant rhabdoid tumor at the craniovertebral junction in a 3-year-old boy.

Takuma Nishimoto1, Sadahiro Nomura2, Reiji Fukano3, Tokuhiro Kimura4, Eiji Ikeda4, Michiyasu Suzuki2.   

Abstract

INTRODUCTION: Malignant rhabdoid tumor (MRT) is a highly aggressive childhood neoplasm and mainly presents in kidney and brain. We report the case of a patient with extrarenal extracranial MRT in the craniovertebral junction (CVJ). CASE REPORT: A 3-year-old boy presented with tetraparesis that had rapidly developed for 2 weeks. The tumor was located in the ventral side of the C1 and C2 extradural space and had invaded the lower clivus. The symptom recovered after subtotal resection of the tumor through a lateral approach with removal of bilateral lateral masses at C1 and instrumental occipital-C2 posterior fusion. Definite histological diagnosis of the extradural tumor was difficult; however, a metastatic lesion in the rib showed a proliferation of INI1/SMARCB1-negative spindle and rhabdoid cells, indicating the tumor was MRT. Stereotactic CyberKnife radiotherapy with a marginal dose of 26 Gy contributed to control of local regrowth of the tumor before histopathological confirmation and induction of chemotherapy with ifosfamide, cisplatin, and etoposide. The patient survived for 29 months without local recurrence of the tumor and with independent activity, however then died of multiple metastases.
CONCLUSION: Treatment strategies for MRT in the CVJ should include an optimal surgical approach for reduction of tumor volume and stabilization of the spine, followed by high dose chemotherapy. Stereotactic radiotherapy may be useful for local control.

Entities:  

Keywords:  Extradural tumor; INI1/SMARCB1/BAF47; Pediatrics; Posterior fusion

Mesh:

Year:  2017        PMID: 29086074     DOI: 10.1007/s00381-017-3631-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  14 in total

1.  A primary spinal extradural atypical teratoid/rhabdoid tumor of the cervical spine with bony involvement.

Authors:  Xiaoyan Xin; Bin Zhu; Jingtao Shen; Chuanshuai Tian; Xiangshan Fan; Bao-rui Liu
Journal:  J Child Neurol       Date:  2014-01-05       Impact factor: 1.987

2.  Clinicopathological characteristics of atypical teratoid/rhabdoid tumor.

Authors:  H Oka; B W Scheithauer
Journal:  Neurol Med Chir (Tokyo)       Date:  1999-07       Impact factor: 1.742

3.  Change in lordosis at the occipitocervical junction following posterior occipitocervical fusion in skeletally immature children.

Authors:  Brian P D Wills; Joshua D Auerbach; Michael P Glotzbecker; Denis S Drummond; John P Dormans
Journal:  Spine (Phila Pa 1976)       Date:  2006-09-15       Impact factor: 3.468

4.  Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.

Authors:  Jaclyn A Biegel; Lu Tan; Fan Zhang; Luanne Wainwright; Pierre Russo; Lucy B Rorke
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

Review 5.  Molecular genetics of atypical teratoid/rhabdoid tumor.

Authors:  Jaclyn A Biegel
Journal:  Neurosurg Focus       Date:  2006-01-15       Impact factor: 4.047

6.  An extrarenal rhabdoid tumor of the cervical spine with bony involvement.

Authors:  C Robbens; R Vanwyck; G Wilms; R Sciot; M Debiec-Rychter
Journal:  Skeletal Radiol       Date:  2006-04-07       Impact factor: 2.199

7.  Extrarenal rhabdoid tumor mimicking a sacral peripheral nerve sheath tumor.

Authors:  Matthew D Dobbs; Hernan Correa; Herbert S Schwartz; J Herman Kan
Journal:  Skeletal Radiol       Date:  2011-04-09       Impact factor: 2.199

8.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity.

Authors:  L B Rorke; R J Packer; J A Biegel
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

Review 9.  Pathology and diagnosis of SMARCB1-deficient tumors.

Authors:  Ashley S Margol; Alexander R Judkins
Journal:  Cancer Genet       Date:  2014-08-01

10.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.